# Einstein-Mount Sinai Diabetes Research Center

> **NIH NIH P30** · ALBERT EINSTEIN COLLEGE OF MEDICINE · 2021 · $487,482

## Abstract

SUMMARY/ABSTRACT:
 Due to the high mortality (>2% of infected individuals world-wide) with ~25% of infected
individuals developing post-acute COVID-19 syndromes, the National Institute of Diabetes,
Digestive and Kidney Diseases (NIDDK) organized a taskforce composed of Diabetes Research
Centers (DRCs) and Centers for Diabetes Translational Research (CDTRs) to explore research
directions that should be harnessed to address the issues associated with COVID-19 and
metabolism. Two related efforts were broadly agreed upon to be of important current and future
value and were endorsed at the Spring NIDDK Council meeting. This application for a
Supplement represents our formal request for NIDDK funds to support these two novel research
programs that will take advantage of the established of the NIDDK funded DRC and CDTR
infrastructures.
 Within this framework, there are two overarching goals. The immediate goal is to foster
COVID-19 metabolism research which leverages the existing technologies and strengths that
exist with the national DRC and CDTR programs. The long-term goal is to develop a work flow
for expanding national research collaborations across the diabetes/obesity and metabolic
disease research communities at the basic, clinical, translational, community and health
disparity levels. To accomplish these objectives, we propose 1) To establish a national Pilot &
Feasibility (P&F) award program to fund collaborative research projects directly related to
COVID-19 and metabolism; 2) To establish a national mini-grant research award program to
fund projects directly related to COVID-19 and metabolism that will specifically use DRC and/or
CDTR Biomedical Core facilities; 3) To develop and oversee an effective process for the
solicitation and review of grant applications; and 4) To establish the Albert Einstein College of
Medicine as a central site for the collection, management and distribution of funds that will be
used to support the national P&F and mini-grant programs.

## Key facts

- **NIH application ID:** 10481184
- **Project number:** 3P30DK020541-46S1
- **Recipient organization:** ALBERT EINSTEIN COLLEGE OF MEDICINE
- **Principal Investigator:** JEFFREY E. PESSIN
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $487,482
- **Award type:** 3
- **Project period:** 1996-12-01 → 2025-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10481184

## Citation

> US National Institutes of Health, RePORTER application 10481184, Einstein-Mount Sinai Diabetes Research Center (3P30DK020541-46S1). Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/grant/nih/10481184. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*